|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.278
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.277
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.270
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.192
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.187
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.163
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.160
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.147
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.142
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.133
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.133
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.132
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.131
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.128
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.124
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.124
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.114
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.099
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.098
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.097
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.087
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.084
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.083
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.082
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.082
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.081
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.081
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.078
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.074
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.073
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
91 |
0.073
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.072
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.070
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.070
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.069
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.069
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.068
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.068
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.068
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.066
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.066
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.065
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.064
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.063
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.061
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.059
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.058
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.058
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.058
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.057
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.057
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.057
|
|
|
|
innate immune response activating signal transduction
|
GO:0002758 |
50 |
0.056
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.056
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.055
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.054
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.054
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.053
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.053
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.052
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.052
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.052
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.052
|
|
|
|
positive regulation of innate immune response
|
GO:0045089 |
80 |
0.050
|
|
|
|
negative regulation of inflammatory response
|
GO:0050728 |
61 |
0.049
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.048
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.047
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.047
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.046
|
|
|
|
adenylate cyclase modulating g protein coupled receptor signaling pathway
|
GO:0007188 |
54 |
0.045
|
|
|
|
pattern recognition receptor signaling pathway
|
GO:0002221 |
47 |
0.044
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.044
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.044
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.043
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.042
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.042
|
|
|
|
positive regulation of cytosolic calcium ion concentration
|
GO:0007204 |
65 |
0.042
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.042
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.042
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.042
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.042
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.041
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.041
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.041
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.041
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.040
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.040
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.040
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.040
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.039
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.039
|
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.038
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.038
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.038
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.038
|
|
|
|
norepinephrine secretion
|
GO:0048243 |
2 |
0.038
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.038
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.038
|
|
|
|
hemostasis
|
GO:0007599 |
78 |
0.037
|
|
|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.037
|
|
|
|
activation of innate immune response
|
GO:0002218 |
56 |
0.037
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.037
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.036
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.036
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.036
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.036
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.036
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.036
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.035
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.035
|
|
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
77 |
0.035
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.034
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.034
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.034
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.034
|
|
|
|
macromolecule glycosylation
|
GO:0043413 |
55 |
0.034
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.034
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.034
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.034
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.033
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.032
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.032
|
|
|
|
glycosylation
|
GO:0070085 |
62 |
0.032
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.032
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.032
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.032
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.032
|
|
|
|
toll like receptor signaling pathway
|
GO:0002224 |
38 |
0.032
|
|
|
|
monocarboxylic acid biosynthetic process
|
GO:0072330 |
61 |
0.032
|
|
|
|
sodium ion transmembrane transport
|
GO:0035725 |
49 |
0.032
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.031
|
|
|
|
neutral lipid metabolic process
|
GO:0006638 |
57 |
0.031
|
|
|
|
liver development
|
GO:0001889 |
66 |
0.031
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.031
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.031
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.031
|
|
|
|
norepinephrine transport
|
GO:0015874 |
2 |
0.031
|
|
|
|
regulation of serotonin secretion
|
GO:0014062 |
3 |
0.030
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.030
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.030
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.030
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.030
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.030
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.030
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.030
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.030
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.030
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.030
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.030
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.030
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.029
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.029
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.029
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.029
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.029
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.029
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.029
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.029
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.028
|
|
|
|
cell differentiation involved in embryonic placenta development
|
GO:0060706 |
26 |
0.028
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.028
|
|
|
|
regulation of tumor necrosis factor production
|
GO:0032680 |
49 |
0.028
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.028
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.028
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.028
|
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
125 |
0.028
|
|
|
|
positive regulation of leukocyte proliferation
|
GO:0070665 |
73 |
0.028
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.028
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.028
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.028
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.028
|
|
|
|
g protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger
|
GO:0007187 |
55 |
0.028
|
|
|
|
positive regulation of inflammatory response
|
GO:0050729 |
47 |
0.028
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.027
|
|
|
|
detection of molecule of bacterial origin
|
GO:0032490 |
2 |
0.027
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.027
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.027
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.027
|
|
|
|
protein glycosylation
|
GO:0006486 |
55 |
0.026
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.026
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.026
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.026
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.026
|
|
|
|
lymphocyte activation involved in immune response
|
GO:0002285 |
93 |
0.025
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.025
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.025
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.025
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.025
|
|
|
|
regulation of tumor necrosis factor superfamily cytokine production
|
GO:1903555 |
50 |
0.025
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.025
|
|
|
|
smooth muscle contraction
|
GO:0006939 |
44 |
0.025
|
|
|
|
body fluid secretion
|
GO:0007589 |
53 |
0.025
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.025
|
|
|
|
defense response to gram positive bacterium
|
GO:0050830 |
50 |
0.024
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.024
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.024
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.024
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.024
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.024
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.024
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.024
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.023
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.023
|
|
|
|
regulation of leukocyte mediated immunity
|
GO:0002703 |
104 |
0.023
|
|
|
|
positive regulation of leukocyte differentiation
|
GO:1902107 |
86 |
0.023
|
|
|
|
response to drug
|
GO:0042493 |
75 |
0.023
|
|
|
|
cytokine metabolic process
|
GO:0042107 |
71 |
0.023
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.023
|
|
|
|
platelet activation
|
GO:0030168 |
40 |
0.023
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.023
|
|
|
|
negative regulation of serotonin secretion
|
GO:0014063 |
2 |
0.023
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.023
|
|
|
|
acute inflammatory response
|
GO:0002526 |
41 |
0.023
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.023
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.022
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.022
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.022
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.022
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.022
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.022
|
|
|
|
cytokine secretion
|
GO:0050663 |
72 |
0.022
|
|
|
|
positive regulation of protein secretion
|
GO:0050714 |
52 |
0.022
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.022
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.022
|
|
|
|
ventricular septum development
|
GO:0003281 |
42 |
0.022
|
|
|
|
positive regulation of cytokine secretion
|
GO:0050715 |
41 |
0.021
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.021
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.021
|
|
|
|
positive regulation of insulin receptor signaling pathway
|
GO:0046628 |
4 |
0.021
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.021
|
|
|
|
cardiac septum development
|
GO:0003279 |
59 |
0.021
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.021
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.020
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.020
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.020
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.020
|
|
|
|
negative regulation of lipid metabolic process
|
GO:0045833 |
30 |
0.020
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.020
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.020
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.020
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.020
|
|
|
|
positive regulation of peptidyl tyrosine phosphorylation
|
GO:0050731 |
61 |
0.020
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.020
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.020
|
|
|
|
positive regulation of response to wounding
|
GO:1903036 |
66 |
0.020
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.020
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.020
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.020
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.019
|
|
|
|
tumor necrosis factor superfamily cytokine production
|
GO:0071706 |
51 |
0.019
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.019
|
|
|
|
negative regulation of endothelial cell migration
|
GO:0010596 |
4 |
0.019
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.019
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.019
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.019
|
|
|
|
sodium ion transport
|
GO:0006814 |
73 |
0.019
|
|
|
|
regulation of b cell activation
|
GO:0050864 |
81 |
0.019
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.019
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.019
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.019
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.019
|
|
|
|
tumor necrosis factor production
|
GO:0032640 |
50 |
0.019
|
|
|
|
fatty acid biosynthetic process
|
GO:0006633 |
41 |
0.019
|
|
|
|
positive regulation of cell growth
|
GO:0030307 |
33 |
0.019
|
|
|
|
positive regulation of leukocyte mediated immunity
|
GO:0002705 |
70 |
0.019
|
|
|
|
negative regulation of blood vessel endothelial cell migration
|
GO:0043537 |
3 |
0.019
|
|
|
|
positive regulation of lymphocyte proliferation
|
GO:0050671 |
70 |
0.019
|
|
|
|
cd4 positive alpha beta t cell differentiation
|
GO:0043367 |
41 |
0.018
|
|
|
|
triglyceride metabolic process
|
GO:0006641 |
51 |
0.018
|
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
103 |
0.018
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.018
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.018
|
|
|
|
regulation of interleukin 1 production
|
GO:0032652 |
26 |
0.018
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.018
|
|
|
|
negative regulation of angiogenesis
|
GO:0016525 |
25 |
0.018
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.018
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
81 |
0.018
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.018
|
|
|
|
adenylate cyclase activating g protein coupled receptor signaling pathway
|
GO:0007189 |
30 |
0.018
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.018
|
|
|
|
cell cell recognition
|
GO:0009988 |
44 |
0.018
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.018
|
|
|
|
positive regulation of natural killer cell chemotaxis
|
GO:2000503 |
1 |
0.017
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.017
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.017
|
|
|
|
negative regulation of endopeptidase activity
|
GO:0010951 |
44 |
0.017
|
|
|
|
myeloid leukocyte activation
|
GO:0002274 |
83 |
0.017
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.017
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.017
|
|
|
|
interleukin 6 production
|
GO:0032635 |
58 |
0.017
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.017
|
|
|
|
positive regulation of catecholamine secretion
|
GO:0033605 |
2 |
0.017
|
|
|
|
response to tumor necrosis factor
|
GO:0034612 |
26 |
0.017
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.017
|
|
|
|
negative regulation of blood vessel morphogenesis
|
GO:2000181 |
25 |
0.017
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.017
|
|
|
|
cholesterol metabolic process
|
GO:0008203 |
56 |
0.017
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.017
|
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.017
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.017
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.017
|
|
|
|
regulation of toll like receptor signaling pathway
|
GO:0034121 |
20 |
0.017
|
|
|
|
regulation of action potential
|
GO:0098900 |
4 |
0.017
|
|
|
|
positive regulation of phospholipase activity
|
GO:0010518 |
3 |
0.017
|
|
|
|
establishment of blood nerve barrier
|
GO:0008065 |
3 |
0.016
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.016
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.016
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.016
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.016
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.016
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.016
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.016
|
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
70 |
0.016
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.016
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.016
|
|
|
|
response to osmotic stress
|
GO:0006970 |
21 |
0.016
|
|
|
|
inorganic anion transport
|
GO:0015698 |
43 |
0.016
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.016
|
|
|
|
acylglycerol metabolic process
|
GO:0006639 |
55 |
0.016
|
|
|
|
regulation of cytokine biosynthetic process
|
GO:0042035 |
59 |
0.016
|
|
|
|
positive regulation of tumor necrosis factor production
|
GO:0032760 |
30 |
0.016
|
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
64 |
0.016
|
|
|
|
positive regulation of ion transport
|
GO:0043270 |
65 |
0.016
|
|
|
|
activation of transmembrane receptor protein tyrosine kinase activity
|
GO:0007171 |
3 |
0.016
|
|
|
|
habituation
|
GO:0046959 |
3 |
0.016
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.016
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.016
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.016
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.016
|
|
|
|
acetylcholine transport
|
GO:0015870 |
2 |
0.016
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.016
|
|
|
|
amino acid transport
|
GO:0006865 |
61 |
0.016
|
|
|
|
cell chemotaxis
|
GO:0060326 |
81 |
0.016
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.016
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.015
|
|
|
|
activation of adenylate cyclase activity
|
GO:0007190 |
4 |
0.015
|
|
|
|
protein kinase b signaling
|
GO:0043491 |
74 |
0.015
|
|
|
|
regulation of lymphocyte differentiation
|
GO:0045619 |
107 |
0.015
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.015
|
|
|
|
cytokine biosynthetic process
|
GO:0042089 |
68 |
0.015
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.015
|
|
|
|
asymmetric stem cell division
|
GO:0098722 |
3 |
0.015
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.015
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.015
|
|
|
|
sa node cell action potential
|
GO:0086015 |
4 |
0.015
|
|
|
|
jnk cascade
|
GO:0007254 |
72 |
0.015
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.015
|
|
|
|
sterol metabolic process
|
GO:0016125 |
58 |
0.015
|
|
|
|
regulation of jnk cascade
|
GO:0046328 |
62 |
0.015
|
|
|
|
cellular response to peptidoglycan
|
GO:0071224 |
4 |
0.015
|
|
|
|
regulation of cyclic nucleotide metabolic process
|
GO:0030799 |
40 |
0.015
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
78 |
0.015
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.015
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.015
|
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.015
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.015
|
|
|
|
positive regulation of adenylate cyclase activity involved in g protein coupled receptor signaling pathway
|
GO:0010579 |
3 |
0.015
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.015
|
|
|
|
ribonucleotide biosynthetic process
|
GO:0009260 |
59 |
0.015
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.015
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.014
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.014
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.014
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.014
|
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.014
|
|
|
|
regulation of lipid biosynthetic process
|
GO:0046890 |
54 |
0.014
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.014
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.014
|
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
82 |
0.014
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.014
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.014
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.014
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.014
|
|
|
|
positive regulation of cellular ph reduction
|
GO:0032849 |
2 |
0.014
|
|
|
|
activation of mapk activity
|
GO:0000187 |
59 |
0.014
|
|
|
|
positive regulation of interleukin 8 production
|
GO:0032757 |
2 |
0.014
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.014
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.014
|
|
|
|
myeloid cell activation involved in immune response
|
GO:0002275 |
34 |
0.014
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.014
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.014
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.014
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.014
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.014
|
|
|
|
regulation of blood coagulation
|
GO:0030193 |
28 |
0.014
|
|
|
|
hepaticobiliary system development
|
GO:0061008 |
67 |
0.014
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.014
|
|
|
|
positive regulation of angiogenesis
|
GO:0045766 |
46 |
0.014
|
|
|
|
leukocyte chemotaxis
|
GO:0030595 |
69 |
0.014
|
|
|
|
glucose metabolic process
|
GO:0006006 |
92 |
0.014
|
|
|
|
regulation of myotube differentiation
|
GO:0010830 |
62 |
0.014
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.013
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.013
|
|
|
|
regulation of norepinephrine secretion
|
GO:0014061 |
2 |
0.013
|
|
|
|
endocrine process
|
GO:0050886 |
39 |
0.013
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.013
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.013
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.013
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.013
|
|
|
|
positive regulation of camp mediated signaling
|
GO:0043950 |
3 |
0.013
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.013
|
|
|
|
citrulline metabolic process
|
GO:0000052 |
3 |
0.013
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.013
|
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.013
|
|
|
|
osteoclast differentiation
|
GO:0030316 |
62 |
0.013
|
|
|
|
activation of nf kappab inducing kinase activity
|
GO:0007250 |
4 |
0.013
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.013
|
|
|
|
alpha amino acid metabolic process
|
GO:1901605 |
59 |
0.013
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.013
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.013
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.013
|
|
|
|
proteoglycan metabolic process
|
GO:0006029 |
38 |
0.013
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.013
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.013
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.013
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.013
|
|
|
|
hexose transport
|
GO:0008645 |
56 |
0.013
|
|
|
|
lipid catabolic process
|
GO:0016042 |
69 |
0.013
|
|
|
|
positive regulation of camp metabolic process
|
GO:0030816 |
19 |
0.013
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.013
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.013
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.013
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.013
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.013
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.013
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.013
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.013
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.013
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
62 |
0.012
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.012
|
|
|
|
protein citrullination
|
GO:0018101 |
2 |
0.012
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.012
|
|
|
|
sa node cell to atrial cardiac muscle cell signalling
|
GO:0086018 |
4 |
0.012
|
|
|
|
regulation of glutamate secretion
|
GO:0014048 |
3 |
0.012
|
|
|
|
bone resorption
|
GO:0045453 |
38 |
0.012
|
|
|
|
sperm egg recognition
|
GO:0035036 |
37 |
0.012
|
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
58 |
0.012
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.012
|
|
|
|
asymmetric neuroblast division
|
GO:0055059 |
1 |
0.012
|
|
|
|
regulation of cytokine secretion
|
GO:0050707 |
61 |
0.012
|
|
|
|
myeloid leukocyte mediated immunity
|
GO:0002444 |
42 |
0.012
|
|
|
|
regulation of epidermis development
|
GO:0045682 |
33 |
0.012
|
|
|
|
regulation of circadian sleep wake cycle sleep
|
GO:0045187 |
3 |
0.012
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.012
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.012
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.012
|
|
|
|
positive regulation of phospholipase c activity
|
GO:0010863 |
2 |
0.012
|
|
|
|
hepatocyte growth factor receptor signaling pathway
|
GO:0048012 |
3 |
0.012
|
|
|
|
negative regulation of vasculature development
|
GO:1901343 |
26 |
0.012
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.012
|
|
|
|
t helper 17 cell lineage commitment
|
GO:0072540 |
4 |
0.012
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.012
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.012
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.012
|
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
64 |
0.012
|
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
69 |
0.012
|
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.012
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.012
|
|
|
|
regulation of renin secretion into blood stream
|
GO:1900133 |
4 |
0.012
|
|
|
|
positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002824 |
61 |
0.012
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.012
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.012
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.012
|
|
|
|
serotonin transport
|
GO:0006837 |
11 |
0.012
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.012
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.012
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.012
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.012
|
|
|
|
interleukin 1 beta production
|
GO:0032611 |
30 |
0.012
|
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.012
|
|
|
|
pulmonary myocardium development
|
GO:0003350 |
3 |
0.011
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.011
|
|
|
|
camp biosynthetic process
|
GO:0006171 |
31 |
0.011
|
|
|
|
cell communication by electrical coupling involved in cardiac conduction
|
GO:0086064 |
2 |
0.011
|
|
|
|
cardiac septum morphogenesis
|
GO:0060411 |
46 |
0.011
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.011
|
|
|
|
binding of sperm to zona pellucida
|
GO:0007339 |
34 |
0.011
|
|
|
|
negative regulation of mapk cascade
|
GO:0043409 |
65 |
0.011
|
|
|
|
cyclic nucleotide metabolic process
|
GO:0009187 |
59 |
0.011
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.011
|
|
|
|
positive regulation of t cell activation
|
GO:0050870 |
101 |
0.011
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.011
|
|
|
|
regulation of monocyte chemotaxis
|
GO:0090025 |
3 |
0.011
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.011
|
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
65 |
0.011
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.011
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.011
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.011
|
|
|
|
transepithelial chloride transport
|
GO:0030321 |
4 |
0.011
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.011
|
|
|
|
phospholipase c activating g protein coupled receptor signaling pathway
|
GO:0007200 |
26 |
0.011
|
|
|
|
placenta blood vessel development
|
GO:0060674 |
31 |
0.011
|
|
|
|
hair follicle morphogenesis
|
GO:0031069 |
29 |
0.011
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.011
|
|